← Evidence map

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models.

Emine Yazici et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42402493